- Physician pay drops, ACOs gain under CMS’ 2027 proposal: 8 things to know
- This psychiatric hospital CEO wants to retire the term ‘co-occurring’
- Physician assistant median pay hits $135K: State-by-state breakdown
- AI in the healthcare workforce: 4 notes
- CHOP increased naloxone co-prescribing from 3% to 84%: Study
- HCA now expects up to $1.2B hit from ACA headwinds
- Teladoc named preferred virtual care provider for NBA players union
- Automation Paid Off—So Why Are Denials Still Rising?
- 3 Russians indicted in $62M cybercrime scheme that hit hospitals
- CMS floats 1.68% cut to physician fee schedule, 7 other things to know
- Orthopedic robotics company lands up to $65M in growth capital
- 25 health systems dropping Medicare Advantage plans | 2026
- HCA names divisional CIO
- Minnesota system names interim CEO
- The America medical education system is not behaving as a normal market
- New York awards $6.3M for mental health clubhouses
- Smile Partners USA continues de novo strategy with new practice
- 988 crisis line tops 23M contacts since launch: 5 things to know
- Bipartisan Senate bill targets ASC Medicare reimbursement gap
- Outpatient care to grow 3x faster than inpatient: Report
- Average gross billings for owner dentists surpassed $1M in 2025
- CMS proposes major Medicare reforms to shift physician pay, phase out MIPS and expand ACO participation
- Specialty Dental Brands selects Videa as its AI platform
- States with the most, fewer psychologists per capita
- Oregon State Hospital named in wrongful death lawsuit
- Mobile care DSO Smile America Partners acquired by investment firm
- With FDA approval for its breast cancer blockbuster hopeful, Celcuity could ‘belong in the hands’ of a Big Pharma
- The specialties winning ASC procedure access — and losing on payment
- Anthropic pushes deeper into healthcare with Optum tie-up, UST integration
- FTC, CVS unveil settlement in ongoing insulin pricing case
- Are ASCs still the right investment? 3 orthopedic surgeons make the case
- What physicians miss when selling their ASC
- Why ASCs may not need a $1.5M spine robot
- North Carolina eye surgeon asks for reversal in CON trial
- HHS promises its final rule barring pediatric gender care providers from Medicare is still coming
- FDA issues psychedelic drug clinical trial guidance: 8 things to know
- AMA interoperability initiative brings structured clinical terminology to CPT codes
- Director's Note on What to Expect at the 2026 Partnerships with Sites Summit
- Rising Tide Dental Partners expands network by 22%, appoints COO
- Lettuce Suspected In Growing Multistate Cyclospora Outbreak
- Startup Sonata launches preventive healthcare membership, linking clinical decisions with AI
- Why Are Family Doctors Leaving The Workforce? Retirement, Burnout Creating A U.S. Primary Care 'Brain Drain'
- HCA Healthcare now expects ACA exchange impacts to exceed $1B in 2026
- Huyabio scores with Opdivo combo in 'milestone' skin cancer trial
- Unruly Patients Are Stressing ER Staff, Undermining Care
- Pain Patients Should Taper Opioids At Their Own Pace, Study Suggests
- Heatwaves Raise Hospital Admissions For Mental Health Woes
- U.S. Gun Suicides Hit Record High, Even As Firearm Deaths Decline Overall
- AstraZeneca pays up to $1.5B for EGFR lung cancer drug Zegfrovy from its spinoff Dizal
- Worried About Your Aging Parents? Welcome To The Caregiving Club
- Knee Pain? Ragged Cartilage? Research Suggests Surgery’s Not the Best Answer
- Lawmakers Look To Make Abortion Shield Laws Less Dependent on Who’s Governor
- Real Chemistry builds body of AI healthcare commercialization tools with Anatomi launch
- Inside agency view: Havas SO on authenticity, connection and pushing back against the ‘sea of sameness’
- Why policy gaps threaten behavioral health coverage
- Specialty dentist pay vs. cost of living by state
- HHS, VA sign agreement to advance psychedelic therapy
- What the de novo boom means for DSOs
- Pearl vs. Videa vs. Overjet: what 3 AI giants have accomplished in 2026
- 8 dental Medicaid updates for dentists to know
- What DSO success looks like in the new age of dentistry
- Cellares' recent automated cell therapy wins have 'opened the biotech floodgates'
- Insulet, Calm join forces for diabetes care offerings with ‘Mind in Range’ wellness tools
- Hospital M&A stays hot in Q2 as health systems position for the future
- 13 behavioral health services, facility closures | 2026
- Cottage Health Expands Partnership with hellocare.ai Following Successful Pilot to Deploy AI Assisted Virtual Care and Patient Safety Platform Enterprise Wide
- North Carolina budget allocates millions for first-ever Rural Emergency Hospital reopening
- Payer-backed ad campaign urges lawmakers to reject NSA enforcement bill
- What Is An Aortic Dissection? The Condition That Killed Sen. Lindsey Graham
- Insurers set to pay out $759M in 2026 MLR rebates: KFF
- Weight-Loss Drugs Help, But Exercise Is Still The Key To A Healthier Heart
- FDA's latest onshoring move homes in on streamlined facility registration, foreign plant scrutiny
- Germany pushes through healthcare reform package despite pharma's drug discount resistance
- GSK to seek FDA approval for Jemperli in small but high-profile cancer use after phase 2 win
- Smartphones Can Increase Seniors' Risk Of Depression
- Pro Soccer Players Show Signs Of Shrinking Brains
- Adderall Misuse Falls Sharply Among Young Adults, Study Finds
- New KFF Poll Reveals Who Is Most Likely To Endorse Vaccine Myths
- A New Option For Long-Term Care Costs
- As GOP Cries Fraud, Newsom Backs Medicaid Spending on Housing and Food
- Lupin recalls more than 2.5M prescription eye drop bottles, citing possible contamination
- Digital health funding hits $7.4B in 2026 as AI investment reshapes the market
- Journalists Discuss Raw-Milk Marketing, Extreme Heat, Opioid Settlement Spending
- Doctors want wearable data but healthcare isn't ready for it, AMA survey finds
- Feds push back HIPAA security rule overhaul to July 2027
- Katie Couric's Memory Loss Scare Puts Rare Brain Condition In Spotlight
- Mild COVID Can Lead To Long-Term Hidden Eye Problems
- Star Padcev-Keytruda combo expands bladder cancer reach with FDA approval, pressuring AstraZeneca
- ACO REACH participants generated nearly $1B in 2024 savings: CMS
- Young people living with PKU take the mic in BioMarin podcast series, TikTok push
- Apollo inks €3B equity deal for stake in Bayer's contraceptives business
- Op-ed: Tackling affordability is a shared responsibility. Here's what hospitals are doing
- Pearl Health banks $110M in fresh funding to build out tech and AI for Medicare providers
- FDA rejects Hengrui, Elevar’s PD-1 liver cancer combo for a 3rd time
- LGBTQ+ People Less Likely To Be Screened For Some Common Cancers
- Smartphone App Uses Voice To Predict Asthma, COPD Flare-Ups
- Seniors Know How Sharp They Are At Any Given Time, Study Finds
- Patients Face A Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- AI Can Detect Previously Invisible MS Scars In The Brain
- They Harvest the Nation’s Food, but a New Rule May Strip Them of Health Insurance
- A New Option for Long-Term Care Costs
- Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector
- Fierce Pharma Asia—More AZ China deals; Kailera, Hengrui’s oral GLP-1 data; Scrutiny of Chinese trials
- J&J’s Tremfya retakes ad spending throne in June as Haleon tops pharma’s World Cup airings
- A $10B deal, China trial scrutiny and highlights from ADA 2026
- Remarks at the Society for Corporate Governance Conference
- GLP-1 Use Hits Record High As Medicare Opens Access To Weight-Loss Drugs
- Beyond Benchmarks: Why Trust Must Be Built into Clinical AI Infrastructure
- Foundation Fights Medical Errors That Claim 200,000 U.S. Lives A Year
- Weekly Rundown: Surgical Safety Technologies rebrands to Aimbient; UC San Diego launches applied health intelligence institute
- New, Highly Accurate Brush Test Can Detect Mouth Cancer Within An Hour
- Innovative Hip Replacement Cuts Post-Surgery Risk Of Dislocation By 70%
- Global Study Finds Kids Worldwide Skipping Fruits And Vegetables
- Affordable Care Act Insurers Want More Premium Increases As Enrollment Sags
- My Search for a Psychiatric Bed in an Overburdened Health System
- How Lee Health Turned Language Access into a Strategic Clinical Asset
- Decision readiness is the next AI advantage
- E. Coli Outbreak Prompts Recall Of Frozen Blueberries At Publix
- Drinking Coffee May Lower Your Risk of Liver Disease
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- Rumination Plays Key Role In Caregiver Stress, Study Says
- U.S. Teens Underestimate Risks Of Fentanyl Use, Survey Finds
- Men More Likely To Be Diagnosed With Advanced Cancer
- Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.
- Training Program Could Ward Off Injuries Among Soccer Girls
- Affordable Care Act Insurers Want More Premium Increases as Enrollment Sags
- Patients Face a Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- Accountability Is Key to Medicaid's Home Care Future
- Clinical Success Is No Longer One Number
- Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
- Michigan, Other States See Unusual Spike In Parasite That Causes 'Explosive' Diarrhea
- Statement on the 2026 Regulatory Agenda
- 9 of the Top 10 Pharma Manufacturers Partner with Redi Health to Lead the Next-Generation Patient Experience
- GLP-1 'Secret Shopper' Study Finds Gaps in Online Prescribing
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
- Fatty Liver Boosts Odds Of More Deadly Colon Cancer, Study Says
- Weight Loss Surgery Increases Risk Of Alcoholism, Study Says
- IV Vitamin C Might Boost Recuperation Among Trauma Patients
- Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.
- SCAN Health Plan, Alignment Healthcare sue to challenge CMS' MA star ratings recalculations
- Regulatory tracker: Eisai, Biogen scoop up subQ Leqembi starter dose nod
- Remarks at the Economic Club of New York
- Is Your Organization Ready to Govern AI in Regulatory Affairs?
- Is Your Organization Ready to Govern AI in Regulatory Affairs?
Michigan healthcare freedom community forum
"Should Texas be allowed to administer “gender-affirming care” to minors? That’s the question at the heart of Senate Bill 14 / House Bill 1686, which seeks to ban it. Proponents of the controversial practice argue that “legislatures shouldn’t be practicing medicine.” But recent testimony from pro-affirming medical professionals before the Texas legislature suggests the need for just such oversight. Delivering false or misleading testimony about minor surgery, mental health, and the evidence backing gender medicine, opponents of the ban inadvertently proved that it is justified.
Start with the question of whether “gender-affirming” surgeries are performed on minors. Last week, physician Cody Miller Pyke assured Texas state senators that “children under the age of eighteen in this country do not have gender reassignment surgery. There isn’t a single case. . . . The rhetoric of mutilating children with scalpels is just fictitious.” Louis Apel, president of the local chapter of the American Academy of Pediatrics, and Jessica Zwiener, a Houston-based endocrinologist, testified that “surgeries are not part of the standard of care for minors.” Zwiener also insisted that “[n]o one is touching these kids’ genitals. There’s not surgery done on minors.”
These physicians are wrong...."
https://www.city-journal.org/article/making-the-case-for-the-other-side
According to Heritage Action, the number of states proposing such bills is now at 40/+.
Heartlander put out this detailed and well-sourced report back in March. Hot links do not copy well, but are available in the original article.
This coming week the Missouri Senate will again see floor debate on Senate Bill 49, legislation designed to protect children from dangerous cross-sex hormones and experimental surgeries.
Especially following the alarming whistleblower reports coming out of the Washington University Transgender Center at St. Louis Children’s Hospital, this common-sense legislation should be an easy win for Missouri families and lawmakers. Senate Democrats, however, continue to block the bill’s path forward.
While left-wing radicals continue to mischaracterize this legislation, it is first important to understand what this law would do, if enacted.
Titled the “Missouri Save Adolescents from Experimentation (SAFE) Act,” this bill would prohibit physicians or other health care providers from providing “sex transition” procedures to minors. The legislation also provides safeguards for medically verifiable disorders of sex development that require medical attention, an important distinction in this highly-charged political debate.
Children, barely of school age, are being subjected to a questionable diagnosis of gender dysphoria that promotes surgeries and prescriptions for cross-sex hormones that are dangerous, life-altering and permanent. This fad-driven form of medical treatment on children is cruel and oftentimes leads to a lifetime of misery, pain and untreated mental illness.
It is wrong to assume everyone advocating for these surgeries and treatments is “doing it for the children.” In fact, providing pharmaceuticals and surgery for children suffering from gender confusion or dysphoria has become a very profitable industry. The surgeries and cross-sex hormone drugs run into the hundreds of thousands of dollars.
This is designer science, scientifically and clinically unproven, and it is being used to target confused parents and vulnerable children for political purposes and for profit. What is certain, however, is that these children will suffer from lifelong medical dependencies that enrich pharmaceutical and medical service providers with little to show in terms of patient benefit.
In reality, after a so-called “sex reassignment” surgery, girls and boys are nearly 20 times more likely to die from suicide than the general population. Up to 98% of children who struggle with their sex as a boy or a girl come to accept their biological sex by adulthood.
The long-term effects of puberty blockers and cross-sex hormones have not been extensively studied. But it’s already clear they can lead to infertility and other irreversible harmful effects that must be dealt with as children mature.
The Missouri Senate is right to focus on protecting children’s health and safety, especially given the recent revelations of negligence, malfeasance, and coercion that have occurred at the Washington University Transgender Center at St. Louis Children’s Hospital. These so-called “transition services” that amputate or severely alter healthy body parts cause irreversible damage that impacts children for the rest of their lives.
Society does not allow minors to get tattoos, purchase cigarettes or vote in elections – we recognize that minors are not ready to make life-altering decisions. Why should children or coerced parents be permitted to allow these cross-sex hormones and surgeries unquestioningly?
Our children deserve quality care and protection from junk science. Body dysphoria, depression anxiety and the awkwardness of puberty are all real challenges that deserve compassion. But, we should not allow our children to be pushed into experimental surgeries and drugs by radical activist groups and rapacious corporations.
This is not a fringe or controversial position for Missouri legislators or citizens to take. All across the United States, state legislatures and governors are now taking a stand to prevent this horrific abuse of minors. Laws similar to Missouri’s SAFE Act have already passed in Alabama, Arkansas, Mississippi, South Dakota, Tennessee, Texas and Utah, with other states such as Georgia and Indiana sure to follow.
Currently, at least 21 states are considering legislation.
Nationwide, parents are demanding the protection of their children from the predatory behaviors of radical school counselors and agenda-driven medical personnel. Missouri policy leaders must join this fight.
The Senate must allow the “Show Me” state to take the lead, and ensure that S.B. 49 sees whatever floor debate is required and pass it on for consideration by the House. Missouri’s kids deserve nothing less.
And now South Carolina, and a roundup of the issue from the Heritage Foundation.
SC Is Protecting Its Children With “Help Not Harm” Bill. More States Should Follow
Mar 14, 2024 3 min read COMMENTARY BY Sarah Parshall Perry, Senior Legal Fellow, Meese CenterAfter passing a Senate subcommittee just days ago, the bill now heads to the full Senate Medical Affairs Committee for a vote. Lawmakers there must show the courage of their colleagues in the House because the bill is precisely the kind of legislation that America’s children need—and need immediately.
In increasing measure, vulnerable pubescent and pre-pubescent children are being proselytized into a fictional belief that they can be “born in the wrong body.” In fact, so effective have been the influences of social media, peer pressure and pro-trans narratives in this space that UCLA School of Law’s Williams Institute reports that more than 300,000 high school-aged (ages 13-17) children in the United States today identify as “transgender”—making them the largest and fastest-growing share of the overall trans-identified population in the country.
Between 2017 and 2021, the number of children in the United States taking puberty blockers or cross-sex hormones doubled. And double mastectomies performed on adolescent girls increased by nearly 400% during the same period.
These increases aren’t organic. They are a direct result of what appears to be a national social experiment targeting children who are not old enough to vote, get tattoos, buy cigarettes or enter into contracts. The federal government has been working overtime to convince the nation that these experimental procedures are “life-saving care” and that if children don’t have access to these “gender affirming” treatments, they will commit suicide.
But the support for such inflammatory rhetoric simply doesn’t exist. We’re being asked to believe that minor children possess the maturity to make life-altering medical decisions and can fully comprehend the risks of these procedures—those that include everything from incontinence to tissue death to lack of fertility, and worse.
Nothing could be further from the truth.
The increase in a new cohort of the population—de-transitioners—is proof positive of the regretfully life-altering and experimental nature of these kind of “gender affirming” medical interventions. It also demonstrates that children, as easily influenced as they are, must not be used as pawns in a political play that caters to a small but vocal and well-funded minority.
This legislation isn’t hateful or bigoted. It’s a common-sense bill that protects minors when the integrity of their bodies and mental health are on the line. It’s also representative of the widespread and bipartisan support for these kinds of bans, as the majority of Americans oppose “gender affirming care” for minors.
But the tide is turning. Several European countries that once uncritically embraced “gender-affirming care” for minors have already reconsidered or reversed course as the lack of evidence supporting the safety of these procedures and increasing evidence of long-term complications surfaces. The FDA is being sued for allegedly concealing records regarding the off-label use of puberty blockers and cross-sex hormones on minors. Medical malpractice claims against hospital systems that rushed minor children into “gender affirming” surgeries with little to no investigation of the minor’s underlying mental health co-morbidities are on the rise.
Nearly two dozen states have already enacted laws prohibiting “gender-affirming” interventions for minors in most circumstances. Now is the time for South Carolina to join them.
This piece originally appeared in MSN
Yesterday, AAPS (Association of American Physicians and Surgeons) emailed this update:
Building on two recent victories — one in Ohio to protect children from irreversible harm, after we filed a strong amicus brief against transgender procedures on minors, and the second in U.S. Court of Appeals for the 11th Circuit (read our amicus) preventing taxpayer funds from being spent on transgender surgery — AAPS is proud to join a coalition led by the American College of Pediatricians asking the Supreme court of the United States to uphold a Tennessee law blocking transgender operations, and use of related drugs, for children.
Link to Amicus in U.S. vs. Skrmetti: https://aapsonline.org/judicial/amicus-skrmetti-10-18-2024.pdf
Meanwhile, NBC News lays out the legal battleground in Texas.
Texas AG sues doctor accused of providing transgender care to 21 minors
The suit is the first by an attorney general against an individual doctor for allegedly violating a restriction on gender-affirming care for minors. By Matt Lavietes and Jo Yurcaba | Oct. 17, 2024Texas Attorney General Ken Paxton sued a Dallas doctor Thursday accusing her of providing transition-related care to nearly two dozen minors in violation of state law.
Paxton alleged that Dr. May Chi Lau, who specializes in adolescent medicine, provided hormone replacement therapy to 21 minors from October 2023 to August for the purpose of transitioning genders. Texas enacted a law, Senate Bill 14, last year banning hormone replacement therapy and other forms of gender-affirming care for minors.
“Texas passed a law to protect children from these dangerous unscientific medical interventions that have irreversible and damaging effects,” Paxton said in a statement Thursday. “Doctors who continue to provide these harmful ‘gender transition’ drugs and treatments will be prosecuted to the full extent of the law.”
The statement alleged that Lau used "false diagnoses and billing codes" to mask "unlawful prescriptions."
Neither Lau nor her employer, the University of Texas Southwestern Medical Center, immediately replied to requests for comment.
If Lau is found to be in violation of the law, her medical license could be revoked and she could face a financial penalty of hundreds of thousands of dollars.
Paxton’s suit is the first in the country by an attorney general against an individual doctor alleging violation of a restriction on transition-related care for minors.
Texas’ law includes a provision that allows physicians to continue to prescribe puberty blockers and hormone therapy to patients who began treatment before June 1, 2023, in order to wean them off the medications “over a period of time and in a manner that is safe and medically appropriate and that minimizes the risk of complications,” according to Paxton’s suit. Minors are required to have attended at least 12 mental health counseling or psychotherapy sessions for at least six months before they started treatment. It’s unclear whether Lau’s treatment of the minors could fall under that provision.
So far, a few attorneys general, including Paxton, have subpoenaed hospitals and practices that provide such care to minors for those patients’ records. Twenty-six states ban at least some forms of gender-affirming care for minors, according to the Movement Advancement Project, an LGBTQ think tank.
Gov. Greg Abbott signed Texas’ restriction in June 2023, and a court blocked it after families and doctors sued. In September 2023, the Texas Supreme Court allowed the law to take effect pending an appeal from the state, and this June, it vacated and reversed the previous injunction, allowing the law to stand.
The U.S. Supreme Court is expected in its current session to hear oral arguments and rule on whether to strike down a similar law in Tennessee. How the court rules on the Tennessee law is expected to affect similar laws in other states.
The statement from Paxton’s office described gender-affirming care as “experimental, and no scientific evidence supports their supposed benefits.”
Major medical organizations, such as the American Medical Association and the American Academy of Pediatrics, disagree, arguing that transition-related care is an effective and medically necessary way to treat gender dysphoria, which is distress felt by people whose gender identities differ from their genders assigned at birth.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
























